Merck, known as MSD outside the U.S. and Canada, announced April 1 the completion of its acquisition of Antelliq Corp. from funds advised by BC Partners.
The announcement positions the company as a global leader in animal health digital tracking, traceability and monitoring technology and complements the existing portfolio of vaccines and pharmaceuticals, the announcement said. Antelliq will be an operating unit within Merck Animal Health.
“The animal health industry is rapidly evolving with revolutionary digital solutions to manage the health and well-being of livestock and companion animals with animal identification, animal monitoring and smart data management as critical components of this technology,” Merck Animal Health president Rick DeLuca said. “We are excited to take this step forward with Antelliq and its brands -- Allflex Livestock Intelligence, Sure Petcare and Biomark -- as we add market-leading technology and services, which extend the range of solutions we can provide to our customers.”
Jean-Baptiste Wautier, partner at BC Partners, said, “We are proud of Antelliq’s transformation over the past five years and believe that Merck is an ideal partner to work with Antelliq’s dynamic leadership team to support the next stage of its growth. As a truly innovative market leader, Antelliq has significant potential to continue spearheading development in the industry, as the use of intelligence, data and technology play an increasingly important role in animal health and care.”
Antelliq's monitoring solutions deliver smart data products and services for the management and well-being of livestock, fish and pets. For more than 60 years, it has been working in 100-plus countries, supported by 22 production sites as well as four regional innovation centers.